Low bone mineral density is related to high physiological levels of free thyroxine in peri-menopausal women

European Journal of Endocrinology

Volumn 170, Issue 3, 2014, Pages 461-468

  Van Rijn, L E ^a   Pop, V J ^b   Williams, G R ^c  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b TILBURG UNIVERSITY   (Netherlands)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROXINE;

ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; BONE DENSITY; CLIMACTERIUM; COHORT ANALYSIS; CONTROLLED STUDY; DUTCH; ETHNIC GROUP; EUTHYROIDISM; FEMALE; FREE THYROXINE INDEX; HUMAN; LUMBAR SPINE; MENOPAUSE; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL; REFERENCE VALUE; SMOKING; THYROID FUNCTION; THYROID FUNCTION TEST; THYROTROPIN BLOOD LEVEL;

BONE DENSITY; BONE DISEASES, METABOLIC; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IODIDE PEROXIDASE; LOGISTIC MODELS; LUMBAR VERTEBRAE; MIDDLE AGED; NETHERLANDS; OSTEOPOROSIS, POSTMENOPAUSAL; POSTMENOPAUSE; PREVALENCE; THYROTROPIN; THYROXINE;

EID: 84896289651     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-13-0769     Document Type: Article

References (28)

1. Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, Franklyn JA, Hershman JM, Burman KD, Denke MA et al. Subclinical thyroid disease; scientific review and guidelines for diagnosis and management. Journal of the American Medical Association 2004 291 228-238. (doi:10.1001/jama.291.2.228)
2. Goichot B, Vinzio S, Kuhn JM, Ladsous M, Proust-Lemoine E, Wemeau JL, Caron P, Orgiazzi J, Luca F, Schneegans O, Schlienger JL & the PIRHATES investigators. Subclinical hyperthyroidism (SCH): to treat or not to treat? What do our patients prefer in the context of a randomized study? Data from the PIRHATES study. Abstract Submissions for ITC Clinical Thyroidology - Subclinical Thyroid Diseases ITC2010-1690 (http://www.thyroid.org/wp-content/uploads/2012/ 04/BAT-prog-final.pdf), 2012.
3. Biondi B & Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocrine Reviews 2008 29 76-131. (doi:10.1210/er.2006- 0043)
4. Cooper DS & Biondi B. Subclinical thyroid disease. Lancet 2012 379 1142-1154. (doi:10.1016/S0140-6736(11)60276-6)
5. Bassett JH & Williams GR. Critical role of the hypothalamic- pituitary-thyroid axis in bone. Bone 2008 43 418-426. (doi:10.1016/j.bone.2008. 05.007)
6. Gogakos AI, Duncan Bassett JH & Willliams GR. Thyroid and bone. Archives of Biochemistry and Biophysics 2010 503 129-136. (doi:10.1016/j.abb. 2010.06.021)
7. Hansen PS, Brix TH, Sorensen TI, Kyvik KO & Hegedus L. Major genetic influence on the regulation of the pituitary-thyroid axis: a study of healthy Danish twins. Journal of Clinical Endocrinology and Metabolism 2004 89 1181-1187. (doi:10.1210/jc.2003-031641)
8. 3 in normal subjects: a clue to the understanding of subclinical thyroid disease. Journal of Clinical Endocrinology and Metabolism 2002 87 1068-1072. (doi:10.1210/jc.87.3.1068)
9. Bassett JH, Boyde A, Howell PG, Bassett RH, Galliforda TM, Archancoa M, Evanse H, Lawsone MA, Crouchere P, St Germain DL et al. Optimal bone strength and mineralization requires the type 2 iodothyronine deiodinase in osteoblasts. PNAS 2012 107 7604-7609. (doi:10.1073/pnas.0911346107)
10. Murphy E, Gluer CC, Reid DM, Felsenberg D, Roux C, Eastell R & Williams GR. Thyroid function within the upper normal range is associated with reduced bone mineral density and an increased risk of nonvertebral fractures in healthy euthyroid postmenopausal women. Journal of Clinical Endocrinology and Metabolism 2010 95 3173-3181. (doi:10.1210/jc.2009-2630)
11. Lin JD, Pei D, Hsia TL, Wu CZ, Wang K, Chang YL, Hsu CH, Chen YL, Chen KW & Tang SH. The relationship between thyroid function and bone mineral density in euthyroid healthy subjects in Taiwan. Endocrine Research 2011 36 1-8. (doi:10.3109/07435800.2010.514877)
12. Roef G, Lapauw B, Goemaere S, Zmierczak H, Fiers T, Kaufman JM & Taes Y. Thyroid hormone status within the physiological range affects bone mass and density in healthy men at the age of peak bone mass. European Journal of Endocrinology 2011 164 1027-1034. (doi:10.1530/EJE-10-1113)
13. Nicholls JJ, Brassill MJ, Williams GR & Bassett JH. The skeletal consequences of thyrotoxicosis. Journal of Endocrinology 2012 213 209-221. (doi:10.1530/JOE-12-0059)
14. Williams AJ, Robson H, Kester MH, van Leeuwen JP, Shalet SM, Visser TJ & Williams GR. Iodothyronine deiodinase enzyme activities in bone. Bone 2008 43 126-134. (doi:10.1016/j.bone.2008.03.019)
15. Capelo LP, Beber EH, Fonseca TL & Gouveia CH. The monocarboxylate transporter 8 and L-type amino acid transporters 1 and 2 are expressed in mouse skeletons and in osteoblastic MC3T3-E1 cells. Thyroid 2009 19 171-180. (doi:10.1089/thy.2008.0120)
16. Bassett JH, O'Shea PJ, Sriskantharajah S, Rabier B, Boyde A, Howell PGT, Weiss RE, Roux JP, Malaval L, Clement-Lacroix P et al. Thyroid hormone excess rather than thyrotrophin deficiency induces osteoporosis in hyperthyroidism. Molecular Endocrinology 2007 21 1095-1107. (doi:10.1210/me.2007-0033)
17. Smeets-Goevaers CG, Lesusink GL, Papapoulos SE, Maartens LW, Keyzer JJ, Weerdenburg JP, Beijers LM, Zwinderman AH, Knottnerus JA, Pols HA et al. The prevalence of low mineral density in Dutch perimenopausal women: the Eindhoven Perimenopausal Osteoporosis Study. Osteoporosis International 1998 8 404-409. (doi:10.1007/s001980050083)
18. Pop VJ, Maartens LH, Lesusink G, van Son MJ, Knottnerus AA, Ward AM, Metcalfe R & Weetman AP. Are autoimmune thyroid dysfunction and depression related? Journal of Clinical Endocrinology and Metabolism 1998 83 3194-3197. (doi:10.1210/jc.83.9.3194)
19. Melton LJ, Atkinson EJ, Fallon WM, Wahner HW & Riggs B. Long-term fracture prediction by bone mineral assessed at different skeletal sites. Journal of Bone and Mineral Research 1993 8 1227-1233. (doi:10.1002/jbmr. 5650081010)
20. Lipsey M. In Design Sensitivity: Statistical Power for Experimental Research, pp 54-58. Newbury Park, CA: Sage Publications, 1990.
21. Hsieh FY, Block DA & Larsen MD. A simple method of sample size calculation for linear and logistic regression. Statistics in Medicine 1998 17 1623-1634. (doi:10.1002/(SICI)1097-0258(19980730)17:14〈1623::AID- SIM871〉3.0.CO;2-S)
22. Kanis JA, McClosky EV, Johansson H, Strom O, Borgstrom F, Oden A & National Osteoporosis Guideline Group. Case finding for the management of osteoporosis with FRAX - assessment and intervention thresholds for the UK. Osteoporosis International 2008 19 1395-1408. (doi:10.1007/s00198-008-0712-1)
23. De Laet C, Kanis JA, Oden A, Johanson H, Johnell O & Delmas P. Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporosis International 2005 16 1330-1338. (doi:10.1007/s00198-005-1863-y)
24. Kanis JA, Johnell O, Oden A, Johansson H, De Laet C & Eisman JA. Smoking and fracture risk: a meta-analysis. Osteoporosis International 2005 16 222-228. (doi:10.1007/s00198-004-1686-2)
25. 4 levels and the TSHR-Asp727Glu polymorphism on bone: the Rotterdam study. Clinical Endocrinology 2008 68 175-181. (doi:10.1111/j.1365-2265-2007-03016.x)
26. Gorka J, Taylor-Gjevre RM & Arnason T. Metabolic and clinical consequences of hyperthyroidism on bone density, a review. International Journal of Endocrinology 2013 2013 638-649. (doi:10.1155/2013/638727)
27. Papadimitriou A, Papadimitriou DT, Papadopoulou P, Nicolaidou P & Fretzayas A. Low TSH levels are not associated with osteoporosis in childhood. European Journal of Endocrinology 2007 157 221-223. (doi:10.1530/EJE-07-0247)
28. Novack DV. TSH, the bone suppressing hormone. Cell 2003 115 129-130. (doi:10.1016/S0092-8674(03)00812-2)